albuterol has been researched along with Anorectal Diseases in 2 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckardt, VF | 1 |
| Dodt, O | 1 |
| Kanzler, G | 1 |
| Bernhard, G | 1 |
| Wright, JE | 1 |
2 trials available for albuterol and Anorectal Diseases
| Article | Year |
|---|---|
Treatment of proctalgia fugax with salbutamol inhalation.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aerosols; Albuterol; Anal Canal; Cross-Over St | 1996 |
Trial of inhaled salbutamol for proctalgia fugax.
Topics: Administration, Inhalation; Albuterol; Drug Evaluation; Humans; Pain; Patient Compliance; Rectal Dis | 1991 |